A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial. (2017)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-017-1972-x
PubMed Identifier: 28587616
Publication URI: http://europepmc.org/abstract/MED/28587616
Type: Journal Article/Review
Volume: 18
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215